BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11778975)

  • 1. Vinorelbine-associated myelopathy in a patient who previously received paclitaxel: a case report.
    Han JY; Choi BG; Song DH; Ahn JG; Yoon JS; Lee KS
    Med Oncol; 2001; 18(1):95-7. PubMed ID: 11778975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible paclitaxel-induced vocal cord paralysis with later recall with vinorelbine.
    Choi BS; Robins HI
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):345-6. PubMed ID: 18026678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
    Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine--a clinical review.
    Gregory RK; Smith IE
    Br J Cancer; 2000 Jun; 82(12):1907-13. PubMed ID: 10864196
    [No Abstract]   [Full Text] [Related]  

  • 5. Vinorelbine tartrate (Navelbine): drug profile and nursing implications of a new vinca alkaloid.
    Brogden JM; Nevidjon B
    Oncol Nurs Forum; 1995 May; 22(4):635-46. PubMed ID: 7675666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
    Kanazawa J; Morimoto M; Ohmori K
    Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
    Uoshima N; Yoshioka K; Tegoshi H; Wada S; Fujiwara Y; Satake N; Kasamatsu Y; Yokoho S
    Intern Med; 2001 Aug; 40(8):779-82. PubMed ID: 11518124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study.
    Fazeny B; Zifko U; Meryn S; Huber H; Grisold W; Dittrich C
    Cancer Chemother Pharmacol; 1996; 39(1-2):150-6. PubMed ID: 8995513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Goss GD; Logan DM; Newman TE; Evans WK
    Cancer Prev Control; 1997; 1(1):28-38. PubMed ID: 9765724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs in non-small cell lung cancer. An overview.
    Giaccone G
    Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adynamic ileus in a patient with non-small-cell lung cancer after treatment with vinorelbine.
    Liebmann J; Friedman K
    Am J Med; 1996 Dec; 101(6):658-9. PubMed ID: 9003116
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer].
    Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2150-6. PubMed ID: 1359840
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin necrosis from extravasation of vinorelbine.
    Moreno de Vega MJ; Dauden E; Abajo P; Bartolome B; Fraga J; Garcia-Diez A
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):488-90. PubMed ID: 12428844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.
    Aapro MS
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):46-9. PubMed ID: 9364543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer.
    Crawford J; O'Rourke M; Schiller JH; Spiridonidis CH; Yanovich S; Ozer H; Langleben A; Hutchins L; Koletsky A; Clamon G; Burman S; White R; Hohneker J
    J Clin Oncol; 1996 Oct; 14(10):2774-84. PubMed ID: 8874339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of vinorelbine (navelbine) and paclitaxel in patients with refractory non-small cell lung cancer.
    Chang AY; DeVore R; Johnson D
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):19-21. PubMed ID: 8610231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
    J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: vinorelbine (navelbine) in non-small cell lung cancer.
    Crawford J
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Vinorelbine-induced pancreatitis: a case report.
    Raderer M; Kornek G; Scheithauer W
    J Natl Cancer Inst; 1998 Feb; 90(4):329. PubMed ID: 9486821
    [No Abstract]   [Full Text] [Related]  

  • 20. Vinorelbine for non-small cell lung cancer.
    Piccirillo MC; Daniele G; Di Maio M; Bryce J; De Feo G; Del Giudice A; Perrone F; Morabito A
    Expert Opin Drug Saf; 2010 May; 9(3):493-510. PubMed ID: 20350282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.